N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg

Categorie

N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg Les marques, N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg Analogs

N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg Les marques melange

N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg Formule chimique

N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg RX lien

N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg FDA fiche

N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg msds (fiche de securite des materiaux)

N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg Synthese de reference

N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg Poids moleculaire

N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg Point de fusion

N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg H₂O Solubilite

N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg Etat

N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg LogP

N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg Formes pharmaceutiques

N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg Indication

N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg Pharmacologie

N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg Absorption

N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg Toxicite

N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg Information pour les patients

N-Benzyl-3-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide; Bmsc001; 3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside; Bapg Organismes affectes